Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...

Evaluation of Breast Specimens after Neoadjuvant ChemotherapyПодробнее

Neoadjuvant chemotherapy with camrelizumab in esophageal SCC: ESCORT-NEO trialПодробнее

Phase II study of neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with MIBCПодробнее

Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic complete response...Подробнее

Addressing the impact of neoadjuvant treatment for MIBC in the NIAGARA trialПодробнее

Nevena Damjanov, MD, on the outcomes of combining atezolizumab with bevacizumab in HCC patientsПодробнее

Systemic immune response to durvalumab concomitant with neoadjuvant chemotherapy in early stage TNCBПодробнее

Neoadjuvant Treatment for Triple-Negative Breast CancerПодробнее

LCMC3 primary analysis: Neoadjuvant atezolizumab in NSCLCПодробнее

Neoadjuvant atezolizumab for non-metastatic urothelial cancerПодробнее

Transcatheter Management of Tricuspid Regurgitation - What You Need to KnowПодробнее

Echo Assessment of Tricuspid Valve Regurgitation - know when and how to InterveneПодробнее

Neoadjuvant Chemo VS Cytoreductive Surgery in OCПодробнее

NIAGARA: perioperative durvalumab with neoadjuvant chemotherapy in MIBCПодробнее

Neoadjuvant Therapy for Localized Upper Tract Urothelial CarcinomaПодробнее

Nab-Paclitaxel as Neoadjuvant Therapy for Breast CancerПодробнее

Neoadjuvant and Adjuvant Chemotherapy | Part II: Clinical Studies, Side Effects & FutureПодробнее

CT Coronary Angiogram and pacemaker-lead related tricuspid valve regurgitation (leaflet anatomy)Подробнее

How do you assess the lymph nodes prior to initiating treatment with neoadjuvant chemotherapy?Подробнее